These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3880404)

  • 1. Tardive dyskinesia in Tourette syndrome.
    Golden GS
    Pediatr Neurol; 1985; 1(3):192-4. PubMed ID: 3880404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol-induced tardive dyskinesia in a child with Gilles de la Tourette's disease.
    Mizrahi EM; Holtzman D; Tharp B
    Arch Neurol; 1980 Dec; 37(12):780. PubMed ID: 6934716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients.
    Shapiro E; Shapiro AK
    Adv Neurol; 1982; 35():413. PubMed ID: 6959518
    [No Abstract]   [Full Text] [Related]  

  • 4. Gilles de la Tourette's syndrome, tardive dyskinesia, and psychosis in an adolescent.
    Caine ED; Margolin DI; Brown GL; Ebert MH
    Am J Psychiatry; 1978 Feb; 135(2):241-3. PubMed ID: 272123
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive dyskinesia following haloperidol treatment in Tourette's syndrome.
    Riddle MA; Hardin MT; Towbin KE; Leckman JF; Cohen DJ
    Arch Gen Psychiatry; 1987 Jan; 44(1):98-9. PubMed ID: 3467661
    [No Abstract]   [Full Text] [Related]  

  • 6. Tardive dyskinesia in persons with Gilles de la Tourette's disease.
    Caine ED; Polinsky RJ
    Arch Neurol; 1981 Jul; 38(7):471-2. PubMed ID: 6941749
    [No Abstract]   [Full Text] [Related]  

  • 7. Reserpine treatment of comorbid Tourette's disorder and tardive dystonia.
    Rojas VM; Davies RK
    J Clin Psychiatry; 1999 Oct; 60(10):709-10. PubMed ID: 10549693
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacotherapy of Tourette syndrome.
    Caine ED
    Int J Neurol; 1980; 14(1):123-6. PubMed ID: 6959970
    [No Abstract]   [Full Text] [Related]  

  • 9. [Two cases of tardive Tourette syndrome].
    Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of haloperidol in young Tourette syndrome patients.
    Bogomolny A; Erenberg G; Rothner AD
    Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520
    [No Abstract]   [Full Text] [Related]  

  • 11. Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder.
    Bruun RD
    Am J Psychiatry; 1988 May; 145(5):621-4. PubMed ID: 2895987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine in tardive Tourette syndrome.
    Jaffe E; Trémeau F; Sharif Z; Reider R
    Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment approaches in Gilles de la Tourette syndrome.
    Borison RL; Ang L; Hamilton WJ; Diamond BI; Davis JM
    Brain Res Bull; 1983 Aug; 11(2):205-8. PubMed ID: 6578865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating Tourette syndrome with haloperidol: predictors of success.
    Schwabe MJ; Konkol RJ
    Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amantadine in Tourette syndrome.
    Borison RL; Davis JM
    Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960
    [No Abstract]   [Full Text] [Related]  

  • 18. Haloperidol-induced tardive dyskinesia in monkeys.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1976 Nov; 50(3):237-40. PubMed ID: 826968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium carbonate in the treatment of movement disorders. A critical review.
    Yassa R; Ananth J
    Int Pharmacopsychiatry; 1980; 15(5):301-8. PubMed ID: 6114936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
    Beasley CM; Dellva MA; Tamura RN; Morgenstern H; Glazer WM; Ferguson K; Tollefson GD
    Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.